Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies. | Transplantation | 2023 | 36413151 | PubTator, text mining | PubMed |
| An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC. | J Thorac Oncol | 2023 | 36410696 | PubTator, text mining | PubMed |
| Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model. | Cancer Immunol Immunother | 2023 | 36385211 | PubTator, text mining | PubMed |
| NKG2D-mediated cytotoxicity improves after primary surgery for high-grade serous ovarian cancer. | Am J Reprod Immunol | 2023 | 36335434 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer. | Cancer Immunol Immunother | 2023 | 36308553 | PubTator, text mining | PubMed |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. | FEBS Open Bio | 2023 | 36282125 | PubTator, text mining | PubMed |
| Molecular landscape of immune pressure and escape in aplastic anemia. | Leukemia | 2023 | 36253429 | PubTator, text mining | PubMed |
| A signature based on NKG2D ligands to predict the recurrence of hepatocellular carcinoma after radical resection. | Cancer Med | 2023 | 36210637 | PubTator, text mining | PubMed |
| Human natural killer cells: Form, function, and development. | J Allergy Clin Immunol | 2023 | 36195172 | PubTator, text mining | PubMed |
| Physical-Chemical Regulation of Membrane Receptors Dynamics in Viral Invasion and Immune Defense. | J Mol Biol | 2023 | 36007627 | PubTator, text mining | PubMed |
| The exosome: a review of current therapeutic roles and capabilities in human reproduction. | Drug Deliv Transl Res | 2023 | 35980542 | PubTator, text mining | PubMed |
| The roles of extracellular vesicles in the immune system. | Nat Rev Immunol | 2023 | 35927511 | PubTator, text mining | PubMed |
| Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts. | Hepatology | 2023 | 35819312 | PubTator, text mining | PubMed |
| Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients. | Cancer Med | 2023 | 35621244 | PubTator, text mining | PubMed |
| Harnessing Natural Killer Cell-Mediated Innate Immune Responses for Cancer Treatment: Advances and Challenges. | Explor Res Hypothesis Med | 2022 | 41769079 | PubTator, text mining | PubMed |
| Levels of Soluble NKG2D Ligands and Cancer History in Patients Starting Hemodialysis. | Front Nephrol | 2022 | 37674990 | PubTator, text mining | PubMed |
| The burden of rare protein-truncating genetic variants on human lifespan. | Nat Aging | 2022 | 37117740 | PubTator, text mining | PubMed |
| Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia. | Front Oncol | 2022 | 37078002 | PubTator, text mining | PubMed |
| Etiopathogenesis of Psoriasis from Genetic Perspective: An updated Review. | Curr Genomics | 2022 | 36777004 | PubTator, text mining | PubMed |
| Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients. | Front Immunol | 2022 | 36741391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=26